GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 1026 - 1050 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▲
IgM Patient 1 10 moderate
G94576MN
62
IgM Patient 1 22 moderate
G35446HX
62
IgM Patient 1 22 moderate
G65889KE
62
IgM Patient 1 22 moderate
G91237TK
62
IgG Patient 2 15 mild
G82204SH
62
IgM Patient 2 15 mild
G00052MO
62
IgM Patient 2 24 mild
G41200QS
62
IgG Patient 2 3 mild
G16579HJ
62
IgG Patient 2 3 mild
G29011JC
62
IgG Patient 2 3 mild
G78074HX
62
IgM Patient 2 24 mild
G91237TK
62
IgM Patient 3 -180 mild
G38488WF
62
IgG Patient 4 12 mild
G19868AX
62
IgM Patient 4 12 mild
G10789DJ
62
IgG Patient 1 6 moderate
G08340FW
63
IgM Patient 1 10 moderate
G54064FW
63
IgM Patient 1 10 moderate
G90223GH
63
IgM Patient 1 10 moderate
G91237TK
63
IgG Patient 2 3 mild
G58969RU
63
IgG Patient 2 3 mild
G91237TK
63
IgG Patient 3 -180 mild
G00051MO
63
IgM Patient 3 -180 mild
G00053MO
63
IgG Patient 3 11 mild
G47548GA
63
IgG Patient 3 11 mild
G51872EK
63
IgG Patient 3 11 mild
G77974XY
63

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024